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SUMMARY – There are many reasons for abnormal lymphocyte and platelet counts. In this study, 
we aimed to assess the prevalence of thrombocytosis, thrombocytopenia, lymphocytosis and lympho-
cytopenia in patients with lower respiratory tract infection (LRTI) and patients with urinary tract 
infection (UTI). This retrospective study included 52 LRTI patients and 60 UTI patients. Control 
group consisted of 70 healthy individuals admitted to the infectiology outpatient unit. No statistically 
significant relationship was found between the groups of subjects and platelet count. Seven (11.7%) 
UTI patients and four (7.7%) LRTI patients had lymphocytopenia but there was no statistically sig-
nificant relationship between the groups of subjects and lymphocyte count. Study results suggested a 
conclusion that lymphocyte and platelet counts could be within the normal ranges in patients with 
UTI, as well as in those with LRTI.
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Introduction
Thrombocytopenia can be caused by many reasons. 
Drugs, infections and malignancy are some known 
agents that could have an association with thrombocy-
topenia. There is a decrease in platelet count due to 
immune attack in immune thrombocytopenia. Steroid 
treatment is the well-known initial treatment in im-
mune thrombocytopenia. Eliminating the causative 
agent is an initial step in the management of thrombo-
cytopenia induced by infections or drugs. Disseminat-
ed intravascular coagulation, thrombotic thrombocy-
topenic purpura and hemolytic uremic syndrome are 
some other clinical situations that may result in throm-
bocytopenia. Many other reasons such as bone marrow 
failure and congenital diseases could be the etiology of 
thrombocytopenia. Peripheral smear is an initial step 
in the search for the etiology of thrombocytopenia. 
Pseudothrombocytopenia can also be easily differenti-
ated from real thrombocytopenia by peripheral smear.
Thrombocytosis may be seen in myeloproliferative 
disorders. Kodali et al. and Cabello et al. have also re-
ported thrombocytosis in some myelodysplastic syn-
drome patients1,2. Reactive thrombocytosis can be seen 
in iron deficiency anemia, infections and hyposplen-
ism. Lymphocytosis can be found in hematologic ma-
lignancies such as chronic lymphocytic leukemia. Re-
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active lymphocytosis may also develop especially in 
viral infections. Lymphocytopenia can develop after 
chemotherapy and steroid treatment. Lymphocytope-
nia can also be seen in autoimmune diseases and infec-
tions.
Hereby, we aimed to assess the prevalence of 
thrombocytosis, thrombocytopenia, lymphocytosis 
and lymphocytopenia in patients with lower respira-
tory tract infection and patients with urinary tract in-
fection.
Patients and Methods
Data on 70 patients with UTI and 67 patients with 
LRTI were recorded retrospectively from the electron-
ic patient file database in 2017. Concomitant diseases 
in study patients were identified from the electronic 
database. All study patients were free from any cancer 
diagnosis record in the electronic database. Male pa-
tients with hemoglobin level <13 mg/dL and female 
patients with hemoglobin level <12 mg/dL were ex-
cluded from the study.
Patients with UTI were admitted to the infectiol-
ogy outpatient unit between January 2, 2017 and 
March 10, 2017. Some of the patients had known co-
morbidities, some of which could have direct or indi-
rect association with platelet levels. Treatments of 
some diseases might also have associations with plate-
let levels and functions. Therefore, three patients also 
suffering from chronic obstructive pulmonary disease 
(COPD), one patient with hepatitis B infection, one 
patient with systemic lupus erythematosus, one pa-
tient with multiple sclerosis (MS), two patients with 
thyroid diseases, one patient with Parkinson’s disease 
and one patient with coronary artery disease were ex-
cluded from analysis. Consequently, 60 UTI patients 
were classified as UTI group.
Patients with LRTI were admitted to the infectiol-
ogy outpatient unit between January 2, 2017 and 
March 24, 2017. Eight patients also suffering from 
COPD, one patient with Behçet’s disease, two patients 
with asthma, two patients with Alzheimer’s disease, 
one patient with cerebral palsy and one patient with 
cardiac rhythm disorder were excluded from the study. 
Consequently, 52 LRTI patients were classified as 
LRTI group.
Control group included 70 healthy individuals ad-
mitted to the infectiology outpatient clinic between 
January 2, 2017 and April 7, 2017. These control sub-
jects did not have any chronic disease records found in 
the electronic database at the time of outpatient clinic 
admission. These control subjects were also selected 
according to the aforementioned hemoglobin cut-off 
values determined for patients. All patients and con-
trol subjects were aged ≥18 years. Patients aged <18 
years were not included in the study.
Platelet counts <150,000/mm³ were classified as 
thrombocytopenia and platelet counts >450,000/mm³ 
as thrombocytosis. Lymphocyte counts <1,000/mm³ 
were classified as lymphocytopenia and lymphocyte 
counts >4,800/mm³ as lymphocytosis. A HORIBA 
Medical Pentra DF Nexus hematology analyzer 
(HORIBA ABX SAS, France) was the instrument to 
measure blood cells in patients admitted to the infec-
tiology outpatient clinic. A written permission from 
the University of Health Sciences, Ankara Dr. Abdur-
rahman Yurtaslan Oncology Training and Research 
Hospital was obtained for the study.
The SPSS (IBM SPSS Statistics 20) for Windows 
was used on statistical analyses. Cross tabulation and 
Pearson’s χ2-test were used for analysis of the relations 
between two qualitative variables. The level of statisti-
cal significance was set at p<0.05. The study protocol 
was approved by the local hospital Ethics Committee 
(decision no.: 2017-11/02).
Results
The mean age of the UTI group patients and LRTI 
group patients was 53.9 and 51.9231 years, respective-
ly. The mean age of control group subjects was 30.6964 
years. Seven (11.7%) UTI patients, four (7.7%) LRTI 
patients and one (1.4%) control subject had lympho-
cytopenia. On the other hand, one (1.6%) UTI patient 
and one (1.9%) LRTI patient had lymphocytosis. 
However, there was no statistically significant relation-
ship between the groups and lymphocyte count 
(p>0.05) (Table 1).
Four (6.7%) UTI patients, five (9.6%) LRTI pa-
tients and one (1.4%) control subject had thrombocy-
topenia. In addition, two (3.8%) LRTI patients and 
one (1.4%) control subject but none of UTI patients 
had thrombocytosis. There was no statistically signifi-
cant relationship between the groups and platelet 
count (p>0.05) (Table 1).
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Discussion
Güngör et al. found 25% of LRTI patients to have 
thrombocytosis, and platelet counts >500,000/mm³ 
were classified as thrombocytosis in their study3. We 
found 3.8% of our LRTI patients to have throm-
bocytosis. However, we analyzed platelet levels in 52 
LRTI patients, whereas the above-mentioned study 
included 20 LRTI patients. In addition, we analyzed 
data on patients admitted to the infectiology outpa-
tient unit, whereas Güngör et al. analyzed data on pa-
tients hospitalized in a pediatric inpatient unit3. Fur-
thermore, Catal et al. showed the mean platelet count 
to be significantly higher in children with culture-
proven upper UTI as compared to controls4. We did 
not find any statistically significant relationship be-
tween the groups and platelet count. Additionally, 
Wyllie et al. report on the association between lym-
phocytopenia and bacteremia5, whereas de Jager et al. 
showed that lymphocytopenia could be useful to pre-
dict bacteremia6. In our study, the prevalence of lym-
phocytopenia was higher in the UTI group than in the 
LRTI group. However, we found no statistically sig-
nificant relationship between the groups and lympho-
cyte count. On the other hand, bacteremia was not an 
inclusion criterion in our study.
We did not search for pseudothrombocytopenia in 
our study. Pseudothrombocytopenia is not a very fre-
quent situation. Silvestri et al. report on the 15.3% 
prevalence of ethylenediaminetetraacetic acid-depen-
dent pseudothrombocytopenia among 111 patients 
referred to their outpatient clinic for isolated throm-
bocytopenia7. Excluding pseudothrombocytopenia 
might increase accuracy in the studies assessing plate-
let levels in hemogram. There are many reasons affect-
ing platelet and lymphocyte counts. We tried to ex-
clude patients with known concomitant factors that 
could influence blood cell counts. However, these ex-
clusions may not have been enough because of the ret-
rospective design of the study. Further prospective 
studies that will exclude all concomitant effects can 
make more specific evaluations in this area.
In conclusion, lymphocyte and platelet counts 
might be within the normal ranges in patients with 
UTI, as well as in patients with LRTI.
Acknowledgment
We want to thank Melih Uzunoğlu from Gazi 
University for his support in statistical analysis. We 
also want to thank Prof. Mustafa Ertek and Dr. Fatma 
Avcı Merdin for their support during the study.
References
1. Kodali D, Mesa H, Rawal A, et al. Thrombocytosis in myelo-
dysplastic and myelodysplastic/myeloproliferative syndromes. 
Leukemia Lymphoma. 2007;48(12):2375-80. https://doi.org/ 
10.1080/10428190701724827
2. Cabello AI, Collado R, Ruiz MA, Martínez J, Navarro I, Ferrer 
R, Sosa AM, Carbonell F. A retrospective analysis of myelo-
dysplastic syndromes with thrombocytosis: reclassification of 
the cases by WHO proposals. Leukemia Res. 2005 Apr;29 
(4):365-70. https://doi.org/10.1016/j.leukres.2004.07.014
3. Güngör O, Meral C, Karademir F, Akcan AB, Aydınöz S, Kul 
M, Süleymanoğlu S. Alt solunum yolu enfeksiyonları ve üst üri-
ner sistem enfeksiyonlarında trombositoz oranları ve değer-
Table 1. Lymphocyte and platelet levels according to disease status
Disease status Statistical 































*Cross tabulation and Pearson’s χ2-test were used for analysis of the relations between two qualitative variables; UTI = urinary tract infec-
tion; LRTI = lower respiratory tract infection
Duygu Mert and A. Merdin et al. Platelet and lymphocyte counts in LRTI and UTI patients
66 Acta Clin Croat, Vol. 59, No. 1, 2020
lendirilmesi. ADÜ Tıp Fakültesi Dergisi. 2011;12(2):1-3. (in 
Turkish)
4. Catal F, Bavbek N, Bayrak O, Uz E, Isik B, Karabel M, Degir-
mencioglu H, Mete E, Akcay A. Platelet parameters in children 
with upper urinary tract infection: is there a specific response? 
Ren Fail. 2008;30(4):377-81. doi: 10.1080/08860220801947389
5. Wyllie DH, Bowler ICJW, Peto TEA. Relation between lym-
phopenia and bacteraemia in UK adults with medical emergen-
cies. J Clin Pathol. 2004 Sep;57(9):950-5. doi: 10.1136/
jcp.2004.017335
6. de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink 
J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil-
lymphocyte count ratio predict bacteremia better than conven-
tional infection markers in an emergency care unit. Crit Care. 
2010;14(5):R192. doi: 10.1186/cc9309
7. Silvestri F, Virgolini L, Savignano C, Zaja F, Velisig M, Bacca-
rani M. Incidence and diagnosis of EDTA-dependent pseudo-
thrombocytopenia in a consecutive outpatient population re-
ferred for isolated thrombocytopenia. Vox Sang. 1995;68(1):35-
9. doi:10.1111/j.1423-0410.1995.tb02542.x
Sažetak
UČESTALOST TROMBOCITOZE, TROMBOCITOPENIJE, LIMFOCITOZE  
I LIMFOCITOPENIJE U BOLESNIKA S INFEKCIJOM DONJIH DIŠNIH PUTOVA  
I BOLESNIKA S INFEKCIJOM MOKRAĆNOG SUSTAVA
D. Mert i A. Merdin
Mnogo je razloga koji mogu poremetiti broj limfocita i trombocita. Cilj ovoga istraživanja bio je procijeniti učestalost 
trombocitoze, trombocitopenije, limfocitoze i limfocitopenije u bolesnika s infekcijom donjih dišnih putova (IDDP) i bole-
snika s infekcijom mokraćnog sustava (IMS). Ova retrospektivna studija uključila je 52 bolesnika s IDDP i 60 bolesnika s 
IMS. Kontrolnu skupinu činilo je 70 zdravih osoba primljenih u ambulantu za infektivne bolesti. Nije utvrđena statistički 
značajna povezanost pojedinih skupina ispitanika i broja trombocita. Limfocitopeniju je imalo sedam (11,7%) bolesnika s 
IMS i četiri (7,7%) bolesnika s IDDP, ali nije bilo statistički značajne povezanosti skupina ispitanika i broja limfocita. 
 Rezultati istraživanja ukazuju na zaključak da broj limfocita i trombocita može biti unutar normalnih granica u bolesnika s 
IMS, kao i u onih s IDDP.
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